New Faculty Recruitment to Enhance Resources in Hypertension Research
招募新教师以增强高血压研究资源
基本信息
- 批准号:7936120
- 负责人:
- 金额:$ 65.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAngiotensin IAngiotensin IIAngiotensinogenAngiotensinsAnimalsApoptosisApplications GrantsAppointmentAreaArtsAwarenessBasic ScienceBiomedical ResearchBlood PressureCardiovascular DiseasesCardiovascular systemChronicClinicalComplexCore FacilityDevelopmentDiseaseDoctor of PhilosophyEnvironmentEnzyme InhibitionEquipmentEvaluationExperimental DesignsFacultyFosteringFunctional RNAFundingFutureGenerationsGenesGoalsHeart HypertrophyHomeostasisHormonesHousingHumanHypertensionImmunologyInflammationInfusion proceduresInjuryInstitutionInternationalKidneyKidney DiseasesKnockout MiceLeadLiquid substanceLouisianaMediatingMediator of activation proteinMicroRNAsMissionModelingMolecularMonitorMorphologyMusNursing FacultyPaperPatient CarePeptidyl-Dipeptidase APhenotypePhysiologyPilot ProjectsPlayPostdoctoral FellowPublic Health SchoolsQualifyingRenal HypertensionRenal functionReninRenin-Angiotensin SystemReportingRepressionResearchResearch ActivityResearch InfrastructureResearch PersonnelResourcesRoleScientific SocietiesSodiumTissuesTrainingTropical MedicineUnited States National Institutes of HealthUniversitiesWaterbaseblood pressure regulationenzyme activityenzyme substrateexperienceimprovedmedical schoolsmeetingsmembermultidisciplinaryplanetary Atmospherepost-doctoral trainingpreventprofessorprogramspublic educationresearch study
项目摘要
DESCRIPTION (provided by applicant): The mission of the Tulane Hypertension and Renal Center of Excellence (THRCE) is to stimulate research activities related to cardiovascular, kidney, and hypertension related diseases and is a multidisciplinary Center with members from clinical and basic science departments. This application proposes to augment and expand biomedical research efforts in the area of cardiovascular and hypertension related diseases by hiring one newly independent investigator (Nil) and providing a start-up package and all resources and support needed for the Nil to develop a competitive research program. We propose to appoint Romer A. Gonzalez-Villalobos, MD, PhD, a postdoctoral fellow, as a tenure track assistant professor in the Department of Physiology. With this plan, the center seeks to provide the new faculty with an enriched environment, and enhance the center's research resources by creating a new core for cardiovascular and renal mouse phenotyping. In this regard Dr. Gonzalez is uniquely qualified to perform phenotyping studies in mice by virtue of his academic background, experience and technical training. For the pilot project Dr. Gonzalez- Villalobos has formulated the hypothesis that during Ang ll-induced hypertension, intrarenal ACE-derived Ang II formation is required in order to augment Ang II levels in the kidney that in turn increase sodium and water retention, increase miR-21 expression, and lead to the progressive development of high blood pressure and renal injury. Experiments will be performed in tissue-specific ACE knockout mice in order to address this hypothesis. The plan for fostering and monitoring the NIl includes providing the candidate with the requisite infrastructure, equipment and technical support; establishing an atmosphere conducive to a strong collaborative network; providing a forum for critical evaluation of experimental design, results, papers and grant proposals; and encouraging the candidate's attendance and participation in national and international meetings as well as involvement in scientific societies and active pursuit of funding.
The proposed plan will provide the means to develop and support the new faculty in his quest to improve our understanding of the mechanisms participating in angiotensin II synthesis in the kidneys and its role in the development of hypertension. This is important because angiotensin II is a hormone that plays a major role in the control of renal function, the development of hypertension and kidney damage.
描述(由申请人提供):Tulane高血压和肾脏卓越中心(THRCE)的使命是刺激与心血管,肾脏和高血压相关疾病有关的研究活动,并且是一个多学科中心,来自临床和基础科学部门的成员。该申请建议通过雇用一名新独立的研究者(NIL),提供启动套餐,并提供尼尔需要制定竞争性研究计划所需的所有资源和支持,以增强和扩大与心血管和高血压相关疾病领域的生物医学研究工作。我们建议任命博士后研究员的Romer A. Gonzalez-Villalobos博士,为生理学系的终身助理助理教授。通过该计划,该中心试图为新教师提供丰富的环境,并通过为心血管和肾脏小鼠表型创造新的核心来增强中心的研究资源。在这方面,冈萨雷斯博士由于其学术背景,经验和技术培训而获得了在小鼠中进行表型研究的独特资格。对于试点项目,Gonzalez-Villalobos博士提出了这样的假设,即在ANG LL诱导的高血压期间,需要在肾脏中增加ANG II水平,从而增加钠和水保留水位,并增加miR-21的表达,并导致高血压和肾脏血压损伤的逐步发展。实验将在组织特异性ACE敲除小鼠中进行,以解决这一假设。培养和监视零的计划包括为候选人提供必要的基础设施,设备和技术支持;建立有利于强大协作网络的气氛;提供一个论坛,以评估实验设计,结果,论文和赠款建议;并鼓励候选人参加国家和国际会议,并参与科学社会和积极追求资金。
拟议的计划将提供发展和支持新教师的手段,以提高我们对肾脏中血管紧张素II合成机制的理解及其在高血压发展中的作用。这很重要,因为血管紧张素II是一种激素,在控制肾功能,高血压和肾脏损伤的发展中起着重要作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis Gabriel Navar其他文献
Analysis of the Macula Densa Feedback Hypothesis for Intrinsic Regulation of Renal Vascular Resistance
- DOI:
10.1016/s1474-6670(17)68056-x - 发表时间:
1973-08-01 - 期刊:
- 影响因子:
- 作者:
Luis Gabriel Navar;Ron Darby - 通讯作者:
Ron Darby
Luis Gabriel Navar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luis Gabriel Navar', 18)}}的其他基金
Translational Research in Hypertension and Renal Biology
高血压和肾脏生物学的转化研究
- 批准号:
8708138 - 财政年份:2012
- 资助金额:
$ 65.59万 - 项目类别:
Translational Research in Hypertension and Renal Biology
高血压和肾脏生物学的转化研究
- 批准号:
9113033 - 财政年份:2012
- 资助金额:
$ 65.59万 - 项目类别:
Translational Research in Hypertension and Renal Biology
高血压和肾脏生物学的转化研究
- 批准号:
8517756 - 财政年份:2012
- 资助金额:
$ 65.59万 - 项目类别:
Potential of Urinary AGT as a Novel Biomarker for Intrarenal RAS Activity in T1DM
尿液 AGT 作为 T1DM 肾内 RAS 活性的新型生物标志物的潜力
- 批准号:
8227361 - 财政年份:2012
- 资助金额:
$ 65.59万 - 项目类别:
Potential of Urinary AGT as a Novel Biomarker for Intrarenal RAS Activity in T1DM
尿液 AGT 作为 T1DM 肾内 RAS 活性的新型生物标志物的潜力
- 批准号:
8529516 - 财政年份:2012
- 资助金额:
$ 65.59万 - 项目类别:
Translational Research in Hypertension and Renal Biology
高血压和肾脏生物学的转化研究
- 批准号:
8305272 - 财政年份:2012
- 资助金额:
$ 65.59万 - 项目类别:
TULANE COBRE: MOLECULAR, IMAGING AND ANALYTIC CORE
TULANE COBRE:分子、成像和分析核心
- 批准号:
8360253 - 财政年份:2011
- 资助金额:
$ 65.59万 - 项目类别:
TULANE COBRE IN HYPERTENSION AND RENAL BIOLOGY: ADMIN CORE
TULANE COBRE 在高血压和肾脏生物学中的应用:管理核心
- 批准号:
8360252 - 财政年份:2011
- 资助金额:
$ 65.59万 - 项目类别:
TULANE COBRE: TRANSGENIC & GENE-TARGETED ANIMAL CORE
TULANE COBRE:转基因
- 批准号:
8360254 - 财政年份:2011
- 资助金额:
$ 65.59万 - 项目类别:
相似国自然基金
肿瘤相关成纤维母细胞血管紧张素I型受体通过Giα3关闭Hippo通路重塑肝癌免疫微环境的机制研究
- 批准号:82073157
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
可溶性肾素原受体通过直接激活血管紧张素I型受体诱导内皮功能紊乱和肥胖相关高血压
- 批准号:81930006
- 批准年份:2019
- 资助金额:297 万元
- 项目类别:重点项目
免疫蛋白酶体亚基β2i在心肌重构中的作用及分子机制研究
- 批准号:81900223
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
CFTR与血管紧张素Ⅱ 1型受体结合调控高血压血管重构及药物影响
- 批准号:81773722
- 批准年份:2017
- 资助金额:59.5 万元
- 项目类别:面上项目
急性高血糖诱导脾脏SND1-AGTR1通路参与急性心肌缺血再灌注损伤的机制研究
- 批准号:81570256
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
ANG1-7 as an intervention for Alzheimer's Disease.
ANG1-7 作为阿尔茨海默病的干预措施。
- 批准号:
10592577 - 财政年份:2023
- 资助金额:
$ 65.59万 - 项目类别:
Domain-specific inhibition of angiotensin-converting enzyme as a therapeutic strategy for opioid use disorders
血管紧张素转换酶的域特异性抑制作为阿片类药物使用障碍的治疗策略
- 批准号:
10512191 - 财政年份:2022
- 资助金额:
$ 65.59万 - 项目类别:
Using Cardiac Targeting Peptide to deliver miRNA for molecular reversal of heart failure
使用心脏靶向肽传递 miRNA 以分子逆转心力衰竭
- 批准号:
10481720 - 财政年份:2022
- 资助金额:
$ 65.59万 - 项目类别:
Novel Role of Thrombospondin-1 in Protection against Rupture of Abdominal Aortic Aneurysm
Thrombospondin-1 在预防腹主动脉瘤破裂中的新作用
- 批准号:
10383732 - 财政年份:2021
- 资助金额:
$ 65.59万 - 项目类别:
COVID-19: Multi-Omics Approach to Identify Molecular Mechanisms Responsible for Risk and Resilience to Adverse Outcomes
COVID-19:多组学方法来识别导致风险和不良结果恢复能力的分子机制
- 批准号:
10154323 - 财政年份:2021
- 资助金额:
$ 65.59万 - 项目类别: